Results 271 to 280 of about 126,022 (347)
Marijuana Use by Juveniles: The Effects of Peers, Parents Race, & Drug Abuse Resistance Education.
Daniel J. Moeser
openalex +1 more source
ABSTRACT Introduction Non‐steroidal anti‐inflammatory drugs (NSAIDs) and paracetamol are among the most commonly used medications worldwide. It has been suggested that the misuse of such medications is not uncommon. The objective of the present research was to explore prevalence, reported reasons and psychopathological concomitants related to NSAIDs ...
Francesco Saverio Bersani +8 more
wiley +1 more source
Perspectives on Analgesia in Patients with Nerve Blocks: A Pilot Survey of Perioperative Nurses. [PDF]
Jones JH, Grant SA.
europepmc +1 more source
Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy
ABSTRACT This theoretical integration paper employs a conceptual analysis methodology to synthesize the Gestalt model of self‐as‐process with Psychedelic Somatic Interactional Psychotherapy (PSIP). Unlike traditional psychedelic therapy models that defer therapeutic engagement to postsession integration, PSIP emphasizes an active, directive therapeutic
Travis R. Fox
wiley +1 more source
Mathematical model for the dynamics of alcohol-marijuana co-abuse
Ana Vivas +3 more
openalex +2 more sources
Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021
Abstract Objective To examine the likelihood of experiencing an overdose among women receiving any buprenorphine (with or without naloxone) compared to women receiving methadone during pregnancy. Methods Data from the MATernaL and Infant clinical NetworK (MAT‐LINK), a longitudinal surveillance system of pregnant woman–child dyads using electronic ...
Amy Board +20 more
wiley +1 more source
Talking to Your Patients About Alcohol, Marijuana, and Substance Use During Pregnancy. [PDF]
Hogan CS +4 more
europepmc +1 more source
Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) or “ecstasy,” is a commonly used drug worldwide, including in New Zealand, where 4.8% of the population aged 15 years or over reported using it in a 2023/2024 survey. This study provides additional insights on MDMA prevalence data in New Zealand by reporting toxicology data from Coronial and driving ...
Thomas J. Sheehan +4 more
wiley +1 more source

